FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for diagnosing chronic heart failure in patients with arterial hypertension aged 80 years and older. In the course of outpatient admission, the patients are examined for criteria of senile asthenia syndrome according to the questionnaire “Age is not a hindrance”. If result is 5 and more points, senile asthenia is stated. If results are 3 or 4 points, a short battery of tests of physical functioning is additionally performed, which includes determination of balance in three different positions of feet, assessment of walking speed at 4 meters, a test with rising from a chair, and if patient gains 7 points or less, a senile asthenia is stated. Further, in the patients with detected senile asthenia, the blood plasma NT-proBNP concentration is determined, and if the NT-proBNP concentration is more than 365.9 pg/ml, chronic heart failure is diagnosed.
EFFECT: method is simple, has no contraindications and is well tolerated by patients.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ACUTE RENAL INJURY IN PATIENTS WITH PULMONARY ARTERY THROMBOEMBOLISM USING RISK SCALE | 2024 |
|
RU2830377C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| METHOD OF DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION | 2023 |
|
RU2814392C1 |
| METHOD FOR EARLY DIAGNOSIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES BY ANALYSIS OF HEART RATE VARIABILITY | 2023 |
|
RU2800862C1 |
| A METHOD FOR DIAGNOSING HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CORONARY ARTERY DISEASE ON THE BACKGROUND OF NON-OCCLUSIVE ATHEROSCLEROSIS OF THE CORONARY ARTERIES | 2022 |
|
RU2789429C1 |
| METHOD FOR PREDICTING THE OUTCOME IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON HYPOXIC BIOMARKERS: ENDOGENOUS ERYTHROPOIETIN AND HYPOXIA-INDUCIBLE FACTOR 1 | 2021 |
|
RU2773683C1 |
| METHOD FOR PREDICTATION OF SUPER RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY FOR PATIENTS WITH CHRONIC HEART FAILURE | 2016 |
|
RU2623487C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING FUNCTIONAL CLASS III CHRONIC HEART FAILURE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2807272C1 |
| METHOD OF CHRONIC CARDIAC DECOMPENSATION SEVERITY ASSESSMENT USING QUANTITATIVE CRITERIA FOR CHILDREN WITH INNATE HEART DISEASE | 2010 |
|
RU2438590C2 |
| METHOD FOR PREDICTING THE PROGRESSION OF HEART FAILURE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2796311C1 |
